As the race for a COVID-19 vaccine approval continues, the need for a multi-stakeholder, national vaccine deployment strategy is becoming more urgent. With ambitious dose manufacturing goals and increased pressure to make COVID-19 vaccines accessible to everyone as quickly as possible, it is crucial to identify and understand potential challenges that our health care system will need to overcome. This briefing explored the manufacturing, distribution, delivery, and coverage approaches that will enable nationwide COVID-19 vaccine uptake. Panelists discussed manufacturing and workforce infrastructure, equitable allocation strategy, and payment and coverage tactics for approved COVID-19 vaccines as well as examined facilitators and barriers to a successful nationwide immunization deployment.
This is the final event in Part I of the Alliance for Health Policy’s 2020 Signature Series focused on disruptors and transformers in health care. See previous events in this series here.
- Richard Hughes IV, JD, MPH, Managing Director and Vaccines and Preventive Services Leader, Avalere Health
- Esther Krofah, MPP, Executive Director, FasterCures, a Center of the Milken Institute
- Nicolette Louissaint, Ph.D., Executive Director, Healthcare Ready
- Reed Tuckson, M.D., Managing Director, Tuckson Health Connections; Board Chair, Alliance for Health Policy (moderator)